hotspot -WSS

hotspot

author：fashion 2025-09-06 04:14:13 - browse：82

Telehealth menopause treatment options displayed on cellphones emerging from a crack in the ground. -- health tech coverage from STAT — Molly Ferguson for STAT

At the turn of the century, nearly 18 million women in the United States were battling hot flashes, night sweats, and other symptoms of menopause with hormones. But in 2002, the therapy went into a free-fall when a landmark trial suggested treating menopause with estrogen and progesterone increased the risk of breast cancer and cardiovascular disease. The study was shut down early — and a year later, prescriptions had plummeted to nearly half what they had been in 2001.

More than two decades later, menopause experts have come to think about the results of the trial very differently. Newer research points to more benefits than risks for many healthy women under 60 treating menopause symptoms with hormone therapy. But many women who are good fits still aren’t getting treatment. “The pendulum has been slowly — too slowly — swinging back,” said OB-GYN Mike Green, chief medical officer of menopause telehealth company Winona.

Winona is part of a new generation of virtual-first health care companies aiming to give that pendulum a push. In the last five years, more than a dozen telehealth companies have started up to serve women in and approaching menopause, including with hormone therapy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
Next article： Chinese researcher claims birth of first gene

WSS

The high cost of giving birth even with insurance

In age of alternative facts, a scholarly course on calling out crap

Diabetes management: Digital health tools fall short, study says

Peter Hotez and the public health issue of online harassment

Steward Health Care expansion into Malta flopped

Duchenne breakthrough therapy leaves behind pioneering families

explore

hotspot

explore

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Virginia high school admissions case could be legal follow

As demand for Covid shots wanes, Moderna seeks its next success

Activists slam private health insurers over coverage restrictions

Duchenne breakthrough therapy leaves behind pioneering families

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

What does generative AI mean for health care? We asked experts

The cancer drug shortage isn’t new — and neither are the solutions

BioMarin wins approval for gene therapy to treat hemophilia A

Bring on the sabbaticals for nurses

hotspot

Medicare Advantage insurers pressure Biden for bigger payments

Bright Health sells Medicare Advantage business to Molina

New air purifier tech could be key to improving indoor air quality

Novavax promises a turnaround & Lilly roils the obesity market

Medicare Advantage insurers pressure Biden for bigger payments

In age of alternative facts, a scholarly course on calling out crap

focus

entertainment

leisure time

entertainment